Patients with rheumatoid arthritis who switched biologics incurred higher costs than patients who persisted on biologics. Etanercept appeared to be associated with the lowest costs.
Hiangkiat Tan, MS, BSPharm
Advertisement
Articles by Hiangkiat Tan, MS, BSPharm
Advertisement
Latest Updated Articles
- Cost of Biologic Treatment Persistence or Switching in Rheumatoid Arthritis
Published: July 12th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
3
Value-Based Care Interventions and Management of CKD Progression
4
Defining the Role of Rilzabrutinib in ITP Management
5
